Thompson Siegel & Walmsley LLC Vericel Corp Transaction History

Thompson Siegel & Walmsley LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$30.93 - $59.48 $83,511 - $160,596	-2,700 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$18.53 - $31.5 $9,820 - $16,695	-530 Reduced 16.41%	2,700 $83,000
Q2 2020 Aug 11, 2020	SELL	$8.5 - $15.82 $4,182 - $7,783	-492 Reduced 13.22%	3,230 $45,000
Q1 2020 May 12, 2020	BUY	$7.25 - $19.22 $4,118 - $10,916	568 Added 18.01%	3,722 $34,000
Q2 2019 Aug 12, 2019	BUY	$15.01 - $18.89 $17,696 - $22,271	1,179 Added 59.7%	3,154 $60,000
Q1 2019 May 13, 2019	BUY	$16.23 - $20.29 $32,054 - $40,072	1,975 New	1,975 $0

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.